img

Global Toxoid Vaccines Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Toxoid Vaccines Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

For bacteria that secrete toxins, or harmful chemicals, a toxoid vaccine might be the answer. These vaccines are used when a bacterial toxin is the main cause of illness. Scientists have found that they can inactivate toxins by treating them with formalin, a solution of formaldehyde and sterilized water. Such “detoxified” toxins, called toxoids, are safe for use in vaccines.
When the immune system receives a vaccine containing a harmless toxoid, it learns how to fight off the natural toxin. The immune system produces antibodies that lock onto and block the toxin. Vaccines against diphtheria and tetanus are examples of toxoid vaccines.
Toxoid Vaccines report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Toxoid Vaccines market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals And Clinics and Government Organizations are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Toxoid Vaccines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Toxoid Vaccines key manufacturers include GlaxoSmithKline, Merck, Pfizer, Sanofi Pasteur, AstraZeneca, Bharat Biotech, Shenzhen Kangtai Biological Products, Bausch Health and Emergent Biosolutions, etc. GlaxoSmithKline, Merck, Pfizer are top 3 players and held % sales share in total in 2022.
Toxoid Vaccines can be divided into Monovalent Tetanus Toxoid (TT), Diphtheria, Tetanus and Pertussis (DTaP), etc. Monovalent Tetanus Toxoid (TT) is the mainstream product in the market, accounting for % sales share globally in 2022.
Toxoid Vaccines is widely used in various fields, such as Hospitals And Clinics, Government Organizations, Research and Others, etc. Hospitals And Clinics provides greatest supports to the Toxoid Vaccines industry development. In 2022, global % sales of Toxoid Vaccines went into Hospitals And Clinics filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Toxoid Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GlaxoSmithKline
Merck
Pfizer
Sanofi Pasteur
AstraZeneca
Bharat Biotech
Shenzhen Kangtai Biological Products
Bausch Health
Emergent Biosolutions
Astellas Pharma
Panacea Biotec
Segment by Type
Monovalent Tetanus Toxoid (TT)
Diphtheria
Tetanus
Pertussis (DTaP)
Diphtheria and Tetanus (DT)

Segment by Application


Hospitals And Clinics
Government Organizations
Research
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Toxoid Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Toxoid Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Toxoid Vaccines industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Toxoid Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Toxoid Vaccines introduction, etc. Toxoid Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Toxoid Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Toxoid Vaccines Market Overview
1.1 Toxoid Vaccines Product Overview
1.2 Toxoid Vaccines Market Segment by Type
1.2.1 Monovalent Tetanus Toxoid (TT)
1.2.2 Diphtheria
1.2.3 Tetanus
1.2.4 Pertussis (DTaP)
1.2.5 Diphtheria and Tetanus (DT)
1.3 Global Toxoid Vaccines Market Size by Type
1.3.1 Global Toxoid Vaccines Market Size Overview by Type (2024-2034)
1.3.2 Global Toxoid Vaccines Historic Market Size Review by Type (2024-2024)
1.3.3 Global Toxoid Vaccines Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Toxoid Vaccines Sales Breakdown by Type (2024-2024)
1.4.2 Europe Toxoid Vaccines Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Toxoid Vaccines Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Toxoid Vaccines Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Toxoid Vaccines Sales Breakdown by Type (2024-2024)
2 Global Toxoid Vaccines Market Competition by Company
2.1 Global Top Players by Toxoid Vaccines Sales (2024-2024)
2.2 Global Top Players by Toxoid Vaccines Revenue (2024-2024)
2.3 Global Top Players by Toxoid Vaccines Price (2024-2024)
2.4 Global Top Manufacturers Toxoid Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Toxoid Vaccines Market Competitive Situation and Trends
2.5.1 Toxoid Vaccines Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Toxoid Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Toxoid Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Toxoid Vaccines Market
2.8 Key Manufacturers Toxoid Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Toxoid Vaccines Status and Outlook by Region
3.1 Global Toxoid Vaccines Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Toxoid Vaccines Historic Market Size by Region
3.2.1 Global Toxoid Vaccines Sales in Volume by Region (2024-2024)
3.2.2 Global Toxoid Vaccines Sales in Value by Region (2024-2024)
3.2.3 Global Toxoid Vaccines Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Toxoid Vaccines Forecasted Market Size by Region
3.3.1 Global Toxoid Vaccines Sales in Volume by Region (2024-2034)
3.3.2 Global Toxoid Vaccines Sales in Value by Region (2024-2034)
3.3.3 Global Toxoid Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Toxoid Vaccines by Application
4.1 Toxoid Vaccines Market Segment by Application
4.1.1 Hospitals And Clinics
4.1.2 Government Organizations
4.1.3 Research
4.1.4 Others
4.2 Global Toxoid Vaccines Market Size by Application
4.2.1 Global Toxoid Vaccines Market Size Overview by Application (2024-2034)
4.2.2 Global Toxoid Vaccines Historic Market Size Review by Application (2024-2024)
4.2.3 Global Toxoid Vaccines Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Toxoid Vaccines Sales Breakdown by Application (2024-2024)
4.3.2 Europe Toxoid Vaccines Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Toxoid Vaccines Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Toxoid Vaccines Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Toxoid Vaccines Sales Breakdown by Application (2024-2024)
5 North America Toxoid Vaccines by Country
5.1 North America Toxoid Vaccines Historic Market Size by Country
5.1.1 North America Toxoid Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Toxoid Vaccines Sales in Volume by Country (2024-2024)
5.1.3 North America Toxoid Vaccines Sales in Value by Country (2024-2024)
5.2 North America Toxoid Vaccines Forecasted Market Size by Country
5.2.1 North America Toxoid Vaccines Sales in Volume by Country (2024-2034)
5.2.2 North America Toxoid Vaccines Sales in Value by Country (2024-2034)
6 Europe Toxoid Vaccines by Country
6.1 Europe Toxoid Vaccines Historic Market Size by Country
6.1.1 Europe Toxoid Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Toxoid Vaccines Sales in Volume by Country (2024-2024)
6.1.3 Europe Toxoid Vaccines Sales in Value by Country (2024-2024)
6.2 Europe Toxoid Vaccines Forecasted Market Size by Country
6.2.1 Europe Toxoid Vaccines Sales in Volume by Country (2024-2034)
6.2.2 Europe Toxoid Vaccines Sales in Value by Country (2024-2034)
7 Asia-Pacific Toxoid Vaccines by Region
7.1 Asia-Pacific Toxoid Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Toxoid Vaccines Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Toxoid Vaccines Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Toxoid Vaccines Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Toxoid Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Toxoid Vaccines Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Toxoid Vaccines Sales in Value by Region (2024-2034)
8 Latin America Toxoid Vaccines by Country
8.1 Latin America Toxoid Vaccines Historic Market Size by Country
8.1.1 Latin America Toxoid Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Toxoid Vaccines Sales in Volume by Country (2024-2024)
8.1.3 Latin America Toxoid Vaccines Sales in Value by Country (2024-2024)
8.2 Latin America Toxoid Vaccines Forecasted Market Size by Country
8.2.1 Latin America Toxoid Vaccines Sales in Volume by Country (2024-2034)
8.2.2 Latin America Toxoid Vaccines Sales in Value by Country (2024-2034)
9 Middle East and Africa Toxoid Vaccines by Country
9.1 Middle East and Africa Toxoid Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Toxoid Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Toxoid Vaccines Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Toxoid Vaccines Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Toxoid Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Toxoid Vaccines Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Toxoid Vaccines Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Toxoid Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.1.4 GlaxoSmithKline Toxoid Vaccines Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Toxoid Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Merck Toxoid Vaccines Products Offered
10.2.5 Merck Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Toxoid Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Pfizer Toxoid Vaccines Products Offered
10.3.5 Pfizer Recent Development
10.4 Sanofi Pasteur
10.4.1 Sanofi Pasteur Company Information
10.4.2 Sanofi Pasteur Introduction and Business Overview
10.4.3 Sanofi Pasteur Toxoid Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Sanofi Pasteur Toxoid Vaccines Products Offered
10.4.5 Sanofi Pasteur Recent Development
10.5 AstraZeneca
10.5.1 AstraZeneca Company Information
10.5.2 AstraZeneca Introduction and Business Overview
10.5.3 AstraZeneca Toxoid Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.5.4 AstraZeneca Toxoid Vaccines Products Offered
10.5.5 AstraZeneca Recent Development
10.6 Bharat Biotech
10.6.1 Bharat Biotech Company Information
10.6.2 Bharat Biotech Introduction and Business Overview
10.6.3 Bharat Biotech Toxoid Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Bharat Biotech Toxoid Vaccines Products Offered
10.6.5 Bharat Biotech Recent Development
10.7 Shenzhen Kangtai Biological Products
10.7.1 Shenzhen Kangtai Biological Products Company Information
10.7.2 Shenzhen Kangtai Biological Products Introduction and Business Overview
10.7.3 Shenzhen Kangtai Biological Products Toxoid Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Shenzhen Kangtai Biological Products Toxoid Vaccines Products Offered
10.7.5 Shenzhen Kangtai Biological Products Recent Development
10.8 Bausch Health
10.8.1 Bausch Health Company Information
10.8.2 Bausch Health Introduction and Business Overview
10.8.3 Bausch Health Toxoid Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Bausch Health Toxoid Vaccines Products Offered
10.8.5 Bausch Health Recent Development
10.9 Emergent Biosolutions
10.9.1 Emergent Biosolutions Company Information
10.9.2 Emergent Biosolutions Introduction and Business Overview
10.9.3 Emergent Biosolutions Toxoid Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Emergent Biosolutions Toxoid Vaccines Products Offered
10.9.5 Emergent Biosolutions Recent Development
10.10 Astellas Pharma
10.10.1 Astellas Pharma Company Information
10.10.2 Astellas Pharma Introduction and Business Overview
10.10.3 Astellas Pharma Toxoid Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Astellas Pharma Toxoid Vaccines Products Offered
10.10.5 Astellas Pharma Recent Development
10.11 Panacea Biotec
10.11.1 Panacea Biotec Company Information
10.11.2 Panacea Biotec Introduction and Business Overview
10.11.3 Panacea Biotec Toxoid Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Panacea Biotec Toxoid Vaccines Products Offered
10.11.5 Panacea Biotec Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Toxoid Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Toxoid Vaccines Industrial Chain Analysis
11.4 Toxoid Vaccines Market Dynamics
11.4.1 Toxoid Vaccines Industry Trends
11.4.2 Toxoid Vaccines Market Drivers
11.4.3 Toxoid Vaccines Market Challenges
11.4.4 Toxoid Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Toxoid Vaccines Distributors
12.3 Toxoid Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Monovalent Tetanus Toxoid (TT)
Table 2. Major Company of Diphtheria
Table 3. Major Company of Tetanus
Table 4. Major Company of Pertussis (DTaP)
Table 5. Major Company of Diphtheria and Tetanus (DT)
Table 6. Global Toxoid Vaccines Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 7. Global Toxoid Vaccines Sales by Type (2024-2024) & (K Units)
Table 8. Global Toxoid Vaccines Sales Market Share in Volume by Type (2024-2024)
Table 9. Global Toxoid Vaccines Sales by Type (2024-2024) & (US& Million)
Table 10. Global Toxoid Vaccines Market Share in Value by Type (2024-2024)
Table 11. Global Toxoid Vaccines Price by Type (2024-2024) & (USD/Unit)
Table 12. Global Toxoid Vaccines Sales by Type (2024-2034) & (K Units)
Table 13. Global Toxoid Vaccines Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Toxoid Vaccines Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Toxoid Vaccines Sales Market Share in Value by Type (2024-2034)
Table 16. Global Toxoid Vaccines Price by Type (2024-2034) & (USD/Unit)
Table 17. North America Toxoid Vaccines Sales by Type (2024-2024) & (K Units)
Table 18. North America Toxoid Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 19. Europe Toxoid Vaccines Sales (K Units) by Type (2024-2024)
Table 20. Europe Toxoid Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 21. Asia-Pacific Toxoid Vaccines Sales (K Units) by Type (2024-2024)
Table 22. Asia-Pacific Toxoid Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 23. Latin America Toxoid Vaccines Sales (K Units) by Type (2024-2024)
Table 24. Latin America Toxoid Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 25. Middle East and Africa Toxoid Vaccines Sales (K Units) by Type (2024-2024)
Table 26. Middle East and Africa Toxoid Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 27. Global Toxoid Vaccines Sales by Company (2024-2024) & (K Units)
Table 28. Global Toxoid Vaccines Sales Share by Company (2024-2024)
Table 29. Global Toxoid Vaccines Revenue by Company (2024-2024) & (US$ Million)
Table 30. Global Toxoid Vaccines Revenue Share by Company (2024-2024)
Table 31. Global Market Toxoid Vaccines Price by Company (2024-2024) & (USD/Unit)
Table 32. Global Toxoid Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Toxoid Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Toxoid Vaccines as of 2022)
Table 35. Date of Key Manufacturers Enter into Toxoid Vaccines Market
Table 36. Key Manufacturers Toxoid Vaccines Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Toxoid Vaccines Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 39. Global Toxoid Vaccines Sales by Region (2024-2024) & (K Units)
Table 40. Global Toxoid Vaccines Sales Market Share in Volume by Region (2024-2024)
Table 41. Global Toxoid Vaccines Sales by Region (2024-2024) & (US$ Million)
Table 42. Global Toxoid Vaccines Sales Market Share in Value by Region (2024-2024)
Table 43. Global Toxoid Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 44. Global Toxoid Vaccines Sales by Region (2024-2034) & (K Units)
Table 45. Global Toxoid Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Toxoid Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Toxoid Vaccines Sales Market Share in Value by Region (2024-2034)
Table 48. Global Toxoid Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 49. Global Toxoid Vaccines Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 50. Global Toxoid Vaccines Sales by Application (2024-2024) & (K Units)
Table 51. Global Toxoid Vaccines Sales Market Share in Volume by Application (2024-2024)
Table 52. Global Toxoid Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 53. Global Toxoid Vaccines Sales Market Share in Value by Application (2024-2024)
Table 54. Global Toxoid Vaccines Price by Application (2024-2024) & (USD/Unit)
Table 55. Global Toxoid Vaccines Sales by Application (2024-2034) & (K Units)
Table 56. Global Toxoid Vaccines Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Toxoid Vaccines Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Toxoid Vaccines Sales Market Share in Value by Application (2024-2034)
Table 59. Global Toxoid Vaccines Price by Application (2024-2034) & (USD/Unit)
Table 60. North America Toxoid Vaccines Sales by Application (2024-2024) (K Units)
Table 61. North America Toxoid Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 62. Europe Toxoid Vaccines Sales by Application (2024-2024) (K Units)
Table 63. Europe Toxoid Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 64. Asia-Pacific Toxoid Vaccines Sales by Application (2024-2024) (K Units)
Table 65. Asia-Pacific Toxoid Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 66. Latin America Toxoid Vaccines Sales by Application (2024-2024) (K Units)
Table 67. Latin America Toxoid Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 68. Middle East and Africa Toxoid Vaccines Sales by Application (2024-2024) (K Units)
Table 69. Middle East and Africa Toxoid Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 70. North America Toxoid Vaccines Sales by Country (2024-2024) & (K Units)
Table 71. North America Toxoid Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 72. North America Toxoid Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 73. North America Toxoid Vaccines Sales Market Share in Value by Country (2024-2024)
Table 74. North America Toxoid Vaccines Sales by Country (2024-2034) & (K Units)
Table 75. North America Toxoid Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Toxoid Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Toxoid Vaccines Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Toxoid Vaccines Sales by Country (2024-2024) & (K Units)
Table 79. Europe Toxoid Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 80. Europe Toxoid Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 81. Europe Toxoid Vaccines Sales Market Share in Value by Country (2024-2024)
Table 82. Europe Toxoid Vaccines Sales by Country (2024-2034) & (K Units)
Table 83. Europe Toxoid Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Toxoid Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Toxoid Vaccines Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Toxoid Vaccines Sales by Region (2024-2024) & (K Units)
Table 87. Asia-Pacific Toxoid Vaccines Sales Market Share in Volume by Region (2024-2024)
Table 88. Asia-Pacific Toxoid Vaccines Sales by Region (2024-2024) & (US$ Million)
Table 89. Asia-Pacific Toxoid Vaccines Sales Market Share in Value by Region (2024-2024)
Table 90. Asia-Pacific Toxoid Vaccines Sales by Region (2024-2034) & (K Units)
Table 91. Asia-Pacific Toxoid Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Toxoid Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Toxoid Vaccines Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Toxoid Vaccines Sales by Country (2024-2024) & (K Units)
Table 95. Latin America Toxoid Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 96. Latin America Toxoid Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 97. Latin America Toxoid Vaccines Sales Market Share in Value by Country (2024-2024)
Table 98. Latin America Toxoid Vaccines Sales by Country (2024-2034) & (K Units)
Table 99. Latin America Toxoid Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Toxoid Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Toxoid Vaccines Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Toxoid Vaccines Sales by Country (2024-2024) & (K Units)
Table 103. Middle East and Africa Toxoid Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 104. Middle East and Africa Toxoid Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 105. Middle East and Africa Toxoid Vaccines Sales Market Share in Value by Country (2024-2024)
Table 106. Middle East and Africa Toxoid Vaccines Sales by Country (2024-2034) & (K Units)
Table 107. Middle East and Africa Toxoid Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Toxoid Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Toxoid Vaccines Sales Market Share in Value by Country (2024-2034)
Table 110. GlaxoSmithKline Company Information
Table 111. GlaxoSmithKline Introduction and Business Overview
Table 112. GlaxoSmithKline Toxoid Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 113. GlaxoSmithKline Toxoid Vaccines Product
Table 114. GlaxoSmithKline Recent Development
Table 115. Merck Company Information
Table 116. Merck Introduction and Business Overview
Table 117. Merck Toxoid Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 118. Merck Toxoid Vaccines Product
Table 119. Merck Recent Development
Table 120. Pfizer Company Information
Table 121. Pfizer Introduction and Business Overview
Table 122. Pfizer Toxoid Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 123. Pfizer Toxoid Vaccines Product
Table 124. Pfizer Recent Development
Table 125. Sanofi Pasteur Company Information
Table 126. Sanofi Pasteur Introduction and Business Overview
Table 127. Sanofi Pasteur Toxoid Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 128. Sanofi Pasteur Toxoid Vaccines Product
Table 129. Sanofi Pasteur Recent Development
Table 130. AstraZeneca Company Information
Table 131. AstraZeneca Introduction and Business Overview
Table 132. AstraZeneca Toxoid Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 133. AstraZeneca Toxoid Vaccines Product
Table 134. AstraZeneca Recent Development
Table 135. Bharat Biotech Company Information
Table 136. Bharat Biotech Introduction and Business Overview
Table 137. Bharat Biotech Toxoid Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 138. Bharat Biotech Toxoid Vaccines Product
Table 139. Bharat Biotech Recent Development
Table 140. Shenzhen Kangtai Biological Products Company Information
Table 141. Shenzhen Kangtai Biological Products Introduction and Business Overview
Table 142. Shenzhen Kangtai Biological Products Toxoid Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 143. Shenzhen Kangtai Biological Products Toxoid Vaccines Product
Table 144. Shenzhen Kangtai Biological Products Recent Development
Table 145. Bausch Health Company Information
Table 146. Bausch Health Introduction and Business Overview
Table 147. Bausch Health Toxoid Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 148. Bausch Health Toxoid Vaccines Product
Table 149. Bausch Health Recent Development
Table 150. Emergent Biosolutions Company Information
Table 151. Emergent Biosolutions Introduction and Business Overview
Table 152. Emergent Biosolutions Toxoid Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 153. Emergent Biosolutions Toxoid Vaccines Product
Table 154. Emergent Biosolutions Recent Development
Table 155. Astellas Pharma Company Information
Table 156. Astellas Pharma Introduction and Business Overview
Table 157. Astellas Pharma Toxoid Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 158. Astellas Pharma Toxoid Vaccines Product
Table 159. Astellas Pharma Recent Development
Table 160. Panacea Biotec Company Information
Table 161. Panacea Biotec Introduction and Business Overview
Table 162. Panacea Biotec Toxoid Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 163. Panacea Biotec Toxoid Vaccines Product
Table 164. Panacea Biotec Recent Development
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Toxoid Vaccines Market Trends
Table 168. Toxoid Vaccines Market Drivers
Table 169. Toxoid Vaccines Market Challenges
Table 170. Toxoid Vaccines Market Restraints
Table 171. Toxoid Vaccines Distributors List
Table 172. Toxoid Vaccines Downstream Customers
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Toxoid Vaccines Product Picture
Figure 2. Global Toxoid Vaccines Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Toxoid Vaccines Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Toxoid Vaccines Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Monovalent Tetanus Toxoid (TT)
Figure 6. Global Monovalent Tetanus Toxoid (TT) Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Diphtheria
Figure 8. Global Diphtheria Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Tetanus
Figure 10. Global Tetanus Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Pertussis (DTaP)
Figure 12. Global Pertussis (DTaP) Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Product Picture of Diphtheria and Tetanus (DT)
Figure 14. Global Diphtheria and Tetanus (DT) Sales YoY Growth (2024-2034) & (K Units)
Figure 15. Global Toxoid Vaccines Sales by Type (2024-2034) & (US$ Million)
Figure 16. Global Toxoid Vaccines Sales Market Share by Type in 2022 & 2034
Figure 17. North America Toxoid Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. North America Toxoid Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Europe Toxoid Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Europe Toxoid Vaccines Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Toxoid Vaccines Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Toxoid Vaccines Sales Market Share in Value by Type in 2022
Figure 23. Latin America Toxoid Vaccines Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Toxoid Vaccines Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Toxoid Vaccines Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Toxoid Vaccines Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Toxoid Vaccines Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Toxoid Vaccines Revenue in 2022
Figure 29. Toxoid Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 30. Product Picture of Hospitals And Clinics
Figure 31. Global Hospitals And Clinics Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Government Organizations
Figure 33. Global Government Organizations Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Product Picture of Research
Figure 35. Global Research Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 38. Global Toxoid Vaccines Sales by Application (2024-2034) & (US$ Million)
Figure 39. Global Toxoid Vaccines Sales Market Share by Application in 2022 & 2034
Figure 40. North America Toxoid Vaccines Sales Market Share in Volume by Application in 2022
Figure 41. North America Toxoid Vaccines Sales Market Share in Value by Application in 2022
Figure 42. Europe Toxoid Vaccines Sales Market Share in Volume by Application in 2022
Figure 43. Europe Toxoid Vaccines Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Toxoid Vaccines Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Toxoid Vaccines Sales Market Share in Value by Application in 2022
Figure 46. Latin America Toxoid Vaccines Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Toxoid Vaccines Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Toxoid Vaccines Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Toxoid Vaccines Manufacturing Cost Structure
Figure 51. Toxoid Vaccines Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries